lovastatin has been researched along with Adrenoleukodystrophy in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 9 (64.29) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, KC; Mittal, A | 1 |
Khan, M; Singh, I; Singh, J | 1 |
Contreras, MA; Gilg, AG; Singh, I; Uto, T | 1 |
de Visser, M; Dijkgraaf, MG; Engelen, M; Hijzen, M; Kemp, S; Ofman, R; Poll-The, BT; van der Wardt, LA; van Geel, BM; Wanders, RJ | 1 |
Daley, GQ; Huh, YJ; Hwang, DY; Jang, J; Kang, HC; Kim, DS; Kim, DW; Kim, HS; Kim, JY; Lee, J; Lee, JA; Lim, B; Park, IH; Yoo, JE; Yoon, TM | 1 |
Berger, J; Forss-Petter, S; Weinhofer, I; Zigman, M | 2 |
Imamura, A; Suzuki, Y | 1 |
Bao, XH; Ping, LL; Wang, AH | 1 |
Khan, M; Pahan, K; Singh, I | 1 |
Key, L; Khan, M; Pai, S; Singh, I | 1 |
Barbosa, E; Betros, R; Craver, JR; Curé, JK; Key, LL; Khan, M; Pai, GS; Singh, I | 1 |
Alger, S; Green, A; Köhler, W; Moser, H; Sokolowski, P | 1 |
Bruckert, E; Girard, S; Turpin, G | 1 |
2 review(s) available for lovastatin and Adrenoleukodystrophy
Article | Year |
---|---|
[X-linked adrenoleukodystrophy (ALD)].
Topics: Adrenoleukodystrophy; Age of Onset; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Biomarkers; Bone Marrow Transplantation; Chromosomes, Human, X; Dementia; Diagnosis, Differential; Drug Combinations; Erucic Acids; Fatty Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Magnetic Resonance Imaging; Male; Mutation; Phenylbutyrates; Triolein | 2004 |
[Endocrine disease in adrenoleukodystrophy].
Topics: Adrenal Insufficiency; Adrenoleukodystrophy; Adult; Anticholesteremic Agents; Bone Marrow Transplantation; Child; Child, Preschool; Drug Combinations; Erucic Acids; Female; Genetic Therapy; Humans; Lovastatin; Male; Mass Screening; Phenylbutyrates; Testicular Diseases; Treatment Outcome; Triolein | 2001 |
2 trial(s) available for lovastatin and Adrenoleukodystrophy
Article | Year |
---|---|
Lovastatin in X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Fatty Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pilot Projects | 2010 |
Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients.
Topics: Adrenoleukodystrophy; Adult; Aged; Aspartate Aminotransferases; Child; Creatine Kinase; Fatty Acids; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Middle Aged; Platelet Count; Treatment Outcome | 2000 |
10 other study(ies) available for lovastatin and Adrenoleukodystrophy
Article | Year |
---|---|
Childhood cerebral adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Blood Chemical Analysis; Brain; Child; Diet, Fat-Restricted; Humans; Hyperpigmentation; Lovastatin; Magnetic Resonance Imaging; Male; Nervous System Diseases | 2014 |
Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin.
Topics: Adrenoleukodystrophy; Animals; Cells, Cultured; Cerebrum; Child; Humans; Lovastatin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasmalogens; Rats; Reactive Oxygen Species | 2008 |
Oxidative imbalance in nonstimulated X-adrenoleukodystrophy-derived lymphoblasts.
Topics: Adrenoleukodystrophy; Cell Line; Child; Fatty Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Lovastatin; Lymphocytes; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Oxidation-Reduction; Phosphoproteins; Protein Subunits; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2008 |
Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients.
Topics: Adrenoleukodystrophy; ATP Binding Cassette Transporter, Subfamily D; ATP-Binding Cassette Transporters; Brain; Cell Differentiation; DNA; Excitatory Postsynaptic Potentials; Fatty Acids, Nonesterified; Hematopoietic Stem Cell Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Induced Pluripotent Stem Cells; Lovastatin; Neurons; Oligodendroglia; Phenotype; Phenylbutyrates; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Animals; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily D; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Base Sequence; CCAAT-Enhancer-Binding Proteins; Cell Line; Cells, Cultured; Cholesterol; DNA; DNA-Binding Proteins; Fatty Acids; Gene Expression; Humans; Lovastatin; Mice; Mutagenesis, Site-Directed; Promoter Regions, Genetic; Sterol Regulatory Element Binding Protein 1; Transcription Factors | 2002 |
Cholesterol regulates ABCD2 gene expression: implications for X-linked adrenoleukodstrophy.
Topics: Adrenoleukodystrophy; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily D; ATP-Binding Cassette Transporters; CCAAT-Enhancer-Binding Proteins; Cholesterol; DNA-Binding Proteins; Fatty Acids; Gene Expression Regulation; Humans; Lovastatin; Male; Sterol Regulatory Element Binding Protein 1; Transcription Factors | 2003 |
[Lovastatin induction of the redundant gene: implications for therapy of X-linked adrenoleukodystrophy].
Topics: Adrenoleukodystrophy; Humans; Lovastatin | 2007 |
Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Cells, Cultured; Drug Synergism; Fatty Acids; Fibroblasts; Gene Deletion; Humans; Intracellular Fluid; Lovastatin; Mevalonic Acid; Oxidation-Reduction; Phenylacetates; Skin; X Chromosome | 1998 |
Lovastatin for X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Adult; Aged; Fatty Acids; Genetic Linkage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Middle Aged; X Chromosome | 1998 |
Proceedings of the 4th International Workshop of the Adrenoleukodystrophy International Research Group (ALD-IRG), University of York, 3 September 1998.
Topics: Adrenoleukodystrophy; Adult; Child; Clinical Protocols; Drug Combinations; England; Erucic Acids; Hematopoietic Stem Cell Transplantation; Humans; Hypolipidemic Agents; Lovastatin; Male; Prospective Studies; Retrospective Studies; Triolein | 2000 |